-
How Boehringer Ingelheim is buttressing its US business
10 Oct 2025 20:44 GMT
… approvals now in the books—Boehringer Ingelheim is sharpening its focus on … Top Line,” we dive into Boehringer Ingelheim’s latest regulatory successes, two …
-
FDA Approves Boehringer Ingelheim’s JASCAYD as First PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis
10 Oct 2025 10:42 GMT
Boehringer Ingelheim has received approval from the … Head of Human Pharma at Boehringer Ingelheim. “This is the first time … landscape.”
With JASCAYD’s approval, Boehringer Ingelheim strengthens its leadership in pulmonary …
-
Boehringer Ingelheim's Jascayd receives US FDA approval for oral treatment option for adults with IPF
10 Oct 2025 04:05 GMT
Boehringer Ingelheim’s Jascayd (nerandomilast) tablets has … head of human pharma at Boehringer Ingelheim. “This new step forward, driven … in other geographies to follow.
Boehringer Ingelheim is a biopharmaceutical company active …
-
Boehringer Ingelheim gains Accent preclinical cancer program
09 Oct 2025 19:37 GMT
Immuno-oncology
Boehringer Ingelheim Pharma GmbH & Co KG …
-
Tremfya shows PsA benefits for people with skin of color
13 Oct 2025 16:30 GMT
… from AbbVie, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli …
-
Mechanobiology-Centered Therapy Market Insights and Growth Outlook by Towards Healthcare
13 Oct 2025 13:00 GMT
… ; the round included participation from Boehringer Ingelheim Venture Fund and other investors …
-
Artificial Intelligence’s Evolving Role in Diabetes Care
13 Oct 2025 11:41 GMT
… study; consulting fees from Bayer, Boehringer Ingelheim, Corcept Therapeutics, Diasome, Eli Lilly …
-
PPID research obtained in conjunction with Spillers receives veterinary award
13 Oct 2025 05:41 GMT
… partnership with the Spillers brand, Boehringer Ingelheim Vetmedica, Queensland University of Technology …
-
GPCR Structure-Based Drug Design Market Report 2025: Trends, Growth Drivers & Future Forecast Insights
13 Oct 2025 01:15 GMT
… plc
• Thermo Fisher Scientific Inc.
• Boehringer Ingelheim International GmbH
• WuXi AppTec Co …
-
<![CDATA[Top 5 Articles of the Week: October 5-10]]>
12 Oct 2025 14:57 GMT
… acquisition of spesolimab (Spevigo) from Boehringer Ingelheim, following global regulatory approvals. The …